High level of orexin a observed in the phenylketonuria mouse brain is due to the abnormal expression of prepro-orexin

Biochemical and Biophysical Research Communications

Volumn 317, Issue 2, 2004, Pages 522-526

  Surendran, Sankar ^a   Rady, Peter L ^a   Szucs, Sylvia ^a   Michals Matalon, Kimberlee ^a   Tyring, Stephen K ^a   Matalon, Reuben ^a  

^a University of Texas Medical Branch School of Medicine   (United States)

Author keywords

GABA; Glutamate; Hypocretin; Orexin; Phenylalanine; Phenylketonuria

Indexed keywords

BRAIN PROTEIN; MESSENGER RNA; OREXIN A;

ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN TISSUE; CONTROLLED STUDY; DNA MICROARRAY; GENE EXPRESSION; GENE OVEREXPRESSION; GROWTH REGULATION; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PHENYLKETONURIA; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; UPREGULATION;

ANIMALS; BRAIN; CARRIER PROTEINS; GAMMA-AMINOBUTYRIC ACID; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GLUTAMIC ACID; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; MICE; NEUROPEPTIDES; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PHENYLALANINE; PHENYLKETONURIAS; SIGNAL TRANSDUCTION;

EID: 1842583611     PISSN: 0006291X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbrc.2004.03.079     Document Type: Article

References (47)

1. de Lecea L., Kilduff T.S., Peyron C., Gao X., Foye P.E., Danielson P.E., Fukuhara C., Battenberg E.L., Gautvik V.T., Bartlett II F.S., Frankel W.N., van den Pol A.N., Bloom F.E., Gautvik K.M., Sutcliffe J.G. The hypocretins: hypothalamus-specific peptides with neuroexcitatory activity. Proc. Natl. Acad. Sci. USA. 95:1998;322-327.
2. Sakurai T., Amemiya A., Ishii M., Matsuzaki I., Chemelli R.M., Tanaka H. Orexins and orexin receptors: a family of hypothalamus neuropeptides and G protein-coupled receptors that regulate feeding behavior. Cell. 92:1998;573-585.
3. Nambu T., Sakurai T., Mizukami K., Hosoy Y., Yanagisawa M., Goto K. Distribution of orexin neurons in the adult rat brain. Brain Res. 827:1999;243-260.
4. van den Pol A.N. Hypothalamic hypocretin (orexin): robust innervation of the spinal cord. J. Neurosci. 19:1999;3171-3182.
5. Hagan J.J., Leslie R.A., Patel S., Evans M.L., Wattam T.A., Holmes S., Benham C.D., Taylor S.G., Routledge C., Hemmati P., Munton R.P., Ashmeade T.E., Shah A.S., Hatcher J.P., Hatcher P.D., Jones D.N., Smith M.I., Piper D.C., Hunter A.J., Porter R.A., Upton N. Orexin-A activates locus coeruleus cell firing and increases arousal in the rat. Proc. Natl. Acad. Sci. USA. 96:1999;10911-10916.
6. Hirota K., Kushikata T., Kudo M., Smart D., Matsuki A. Effects of central hypocretin-1 administration on hemodynamic responses in young-adult and middle-aged rats. Brain Res. 981:2003;143-150.
7. Small C.J., Goubillon M.L., Murray J.F., Siddiqui A., Grimshaw S.E., Young H., Sivanesan V., Kalamaianos T., Kennedy A.R., Coen C.W., Bloom S.R., Wilson C.A. Central orexin A has site-specific effects on leutinizing hormone release in female rats. Endocrinology. 144:2003;3225-3236.
8. Orexin/hypocretin system: obesity, narcolepsy and beyond, Drug News Perspect. 15 (2002) 166-174.
9. Surendran S., Campbell G.A., Tyring S.K., Matalon K., McDonald J.D., Matalon R. High levels of orexin A in the brain of the mouse model for phenylketonuria: possible role of orexin A in hyperactivity seen in children with PKU. Neurochem. Res. 28:2003;1891-1894.
10. van den Pol A.N., Gao X.B., Obrietan K., Kilduff T.S., Belousov A.B. Presynaptic and postsynaptic actions and modulation of neuroendocrine neurons by a new hypothalamic peptide, hypocretin/orexin. J. Neurosci. 18:1998;7962-7971.
11. Li Y., Gao X.B., Sakurai T., van den Pol A.N. Hypocretin/orexin excites hypocretin neurons via a local glutamate neuron-A potential mechanism for orchestrating the hypothalamic arousal system. Neuron. 36:2002;1169-1181.
12. Nicoletti F., Magri G., Ingrao F., Bruno V., Catania M.V., Dell'Albani P., Condorilli D.F., Avola R. Excitatory aminoacids stimulate inositol phospholipids hydrolysis and reduce proliferation in cultured astrocytes. J. Neurochem. 54:1990;771-777.
13. Petroff O.A. Glutamate and GABA in the human brain. Neuroscientist. 8:2002;562-573.
14. Surendran S., Rady P.L., Michals-Matalon K., Quast M.J., Rassin D.K., Campbell G.A., Ezell E.L., Wei J., Tyring S.K., Szucs S., Matalon R. Expression of glutamate transporter, GABRA6, serine proteinase inhibitor 2 and low levels of glutamate and GABA in the brain of knock-out mouse for Canavan disease. Brain Res. Bull. 61:2003;427-435.
15. Perry T.L., Hansen S., Tischler B., Buting R., Diamond S. Glutamine depletion in phenylketonuria: a possible cause of the mental defect. New Engl. J. Med. 282:1970;761-766.
16. Kakulas B.A., Hamilton G.J., Mastaglia F.L. Clinical and neuropathological observations in phenylketonuria. Proc. Aust. Assoc. Neurol. 5:1968;155-158.
17. Scriver C.R., Kaufman S., Eisensmith R.C., Woo S.L.C. The hyperphenylalaninemias. Scriver C.R., Beaudet A.L., Sly W.S., Valle D. The Molecular Bases of Inherited Disease. vol. 1:1995;1015-1075 McGraw-Hill, New York.
18. Thompson A.J., Smith I., Kendall B.E., Youl B.D., Brenton D. Magnetic resonance imaging changes in early treated patients with phenylketonuria. Lancet. 337:1991;1224.
19. Aoki K., Siegel F.L. Hyperphenylalaninemia: disaggregation of brain polyribosomes in young rats. Science. 168:1970;129-130.
20. Wooley D.W., van der Hoeven T. Serotonin deficiency in infancy as one cause of a mental defect in phenylketonuria. Science. 144:1964;883-884.
21. Cowie V.A. Neurological and psychiatric aspects of phenylketonuria. Bickel H., Hudson F.P., Woolf L.I. Phenylketonuria and Some Other Inborn Errors of Aminoacid Metabolism. 1971;29-39 George Theme Verlag, Stuttgart.
22. Hendrix M.M.T., van der Schot L.W.A., Slijper F.M.E., Huisman J., Kalverboer A.F. Phenylketonuria and some aspects of emotional development. Eur. J. Pediatr. 153:1994;832-835.
23. Trefz F.K., Schmidt H., Bartholome K., Mahl M., Matthis P., Pecht G. Differential diagnosis and significance of various hyperphenylalaninemias. Bockel H., Wachtel U. Inherited Diseases of Amino acid Metabolism. 1985;86-100 Thieme, Stuttgart.
24. Scriver C.R., Kaufman S., Eisensmith R.C., Woo S.L.C. The hyperphenylalaninemias. Scriver C.R., Beaudet A., Sly W., Valle D. The Metabolic and Molecular Bases of Inherited Diseases. seventh ed. 1995;1015-1075 McGraw-Hill, New York.
25. Folling A. Uber Ausscheidung von phenylbrenztraubensaure in den Harn als Stoffwechselanomalie in verbingdung mit imbezillitat. Hoppe-Seylers Z. Physiol. Chem. 227:1934;169-176.
26. Penrose L.S. Inheritance of phenylpyruvic amenta (phenylketonuria). Lancet. 2:1935;192-194.
27. Kaufman S., Fisher D.B. Pterin-requiring aromatic acid hydroxylases. Hayaishi O. Molecular Mechanisms of Oxygen Activation. 1974;285-369 Academic press, New York.
28. Rouse B., Lockhart L., Matalon R., Azen C., Koch R., Hanley W., Levy H., dela Cruz F., Friedman E. Maternal phenylketonuria pregnancy outcome: a preliminary report of facial dysmorphology and major malformations. J. Inherit. Metab. Dis. 13:1990;289-291.
29. Westwood A., Barr D.G. Phenylketonuria with a progressive neurological disorder not responsive to tetrahydrobiopterin. Acta Paediatr. Scand. 71:1982;859-861.
30. McDonald J.D., Bode V., Dove W., Shedlovsky A. A mouse mutant deficient in phenylalanine hydroxylase. Proc. Natl. Acad. Sci. USA. 87:1990;1965-1967.
31. Matalon R., Surendran S., Michals-Matalon K., Quast M., Jingna W., Ezell E., Szucs S. Future role of large neutral amino acids in transport of phenylalanine into the brain. Pediatrics. 112:2003;1570-1574.
32. Yu W., Murray N.R., Weem C., Chen L., Guo H., Ethridge R., Ceci J.D., Evers B.M., Thompson E.A., Fields A.P. Role cyclooxygenase 2 in protein kinase βII-mediated colon carcinogenesis. J. Biol. Chem. 278:2003;11167-11174. doi:10.1074/jbc.M211424200.
33. Date Y., Ueta Y., Yamashita H., Yamaguchi H., Matsukura S., Kanagawa K., Sakurai T., Yanagisawa M., Nakazato M. Orexins, orexigenic hypothalamic peptides, interact with autonomic, neuroendocrine and neuroregulatory systems. Proc. Natl. Acad. Sci. USA. 96:1999;748-753.
34. Peyron C., Tighe D.K., van den Pol A.N., Lecea L., Heller H.C., Sutcliffe J.G., Kilduff T.S. Neurons containing containing hypocretin (orexin) project to multiple neuronal systems. J. Neurosci. 18:1998;9996-10015.
35. John J., Wu M.F., Kodama T., Siegel J.M. Intravenously administered hypocretin-1 alters brain aminoacid release: an in vivo microdialysis study in rats. J. Physiol. 548:2003;557-562.
36. Erecinska M., Nelson D., Wilson D.F., Silver I.A. Neurotransmitter aminoacids in the CNS.I. Regional changes in aminoacid levels in rat brain during ischemia and reperfusion. Brain Res. 304:1984;9-22.
37. Ariznavarreta C., Castillo C., Segovia G., Mora F., Azcoitia I., Tresgurres J.A. Growth hormone and aging. Homo. 54:2003;132-141.
38. Takkinen K., Pettersson R.F., Kalkkinen N., Palva I., Soderlund H., Kaariainen L. Amino acid sequence of alpha-amylase from Bacillus amyolliquefaciens deduced from the nucleotide sequence of the clone gene. J. Biol. Chem. 258:1983;1007-1013.
39. Callis J., Ho T.H. Multiple molecular forms of the gibberellin-induced alpha-amylase from the aleurone layers of barley seeds. Arch. Biochem. Biophys. 224:1983;224-234.
40. Viskochil D.H. It takes two to tango: mast cell and Schwann cell interactions in neurofibromas. J. Clin. Invest. 112:2003;1761-1791.
41. Bunik V.I. 2-Oxo acid dehydrogenase complexes in redox regulation. Eur. J. Biochem. 270:2003;1036-1042.
42. Soto M., Iborra S., Quijada L., Folgueira C., Alonso C., Requena J.M. Cell- cycle dependent translation of histone mRNAs is the key control point for regulation of histone biosynthesis in Leishmania infantum. Biochem. J. 2004;. (Epub).
43. Weber N.C., Blumenthal S.B., Hartung T., Vollamar A.M., Kiemer A.K. ANP inhibits TNF-alpha-induced endothelial MCP-1 expression-involvement of p38 MAPK and MKP-1. J. Leukoc. Biol. 74:2003;932-941.
44. Tombes R.M., Faison M.O., Turbeville J.M. Organization and evolution of multifunctional Ca(2+)/CaM-dependent protein kinase genes. Gene. 322:2003;17-31.
45. Torre E.R., Coleman S., Yi H., Gutekunst C.A. A protocol for isolation and biochemical characterization of stigmoid bodies from rat brain. J. Neurosci. Methods. 125:2003;27-32.
46. Lee J.Y., Kim J.H., palmiter R.D., Koh J.Y. Zinc released from metallothionein-III may contribute to hippocampal CA1 and thalamic neuronal death following acute brain injury. Exp. Neurol. 184:2003;337-347.
47. Bastianelli E. Distribution of calcium-binding proteins in the cerebellum. Cerebellum. 2:2003;242-262.